Trial intelligence / Profile preview

Alum vaginal solution for treatment of vaginal candidiasis

IRCT20200916048736N1Phase 3Completed

Sponsor
Ahvaz Jundishapur University of Medical Sciences
Start
Nov 2020
Modality
Small Molecules, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Countries
1
01

Overview

Phase 3 trial of aluminium hydroxide in vulvovaginal candidiasis (VVC), sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Nov 2020; status: completed.

02

Drugs

aluminium hydroxide
03

Conditions

vulvovaginal candidiasis (VVC)

Beyond the preview

Go deeper on IRCT20200916048736N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200916048736N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call